Get startedLog in
    Picture of Gracell Biotechnologies logo

    GRCL — Gracell Biotechnologies News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapNeutral
    All News

    AztraZeneca to buy China-based Gracell Biotechnologies in $1.2 bln deal

    Picture of Gracell Biotechnologies logoGracell Biotechnologies
    26/12/2023 07:09
    Dec 26 (Reuters) - AstraZeneca  AZN.L  said on Tuesday
it had agreed to buy China-based Gracell Biotechnologies
 GRCL.O  to support its cell therapy ambitions, in a deal valued
at approximately $1.2 billion. 

 (Reporting by Urvi Dugar in Bengaluru; Editing by Sonia Cheema)
 ((UrviManoj.Dugar@thomsonreuters.com;))

    Recent news on Gracell Biotechnologies

    See all news